News Article

Joe Impicciche keynotes national healthcare conference

Joe Impicciche keynotes national healthcare conference

Ascension President and CEO Joseph Impicciche, JD, MHA, presented a virtual Keynote Interview to kick off Becker’s Hospital Review’s 11th Annual Meeting May 10-27. Joe was one of 12 keynote speakers for the event.

Click here to view his interview.

The nearly 18-minute Keynote Interview involved a virtual conversation between Joe and Becker’s Conference Co-Chair and National Health Care Consultant Rhoda Weiss, PhD. In the conversation, Joe discusses Ascension’s COVID-19 response and efforts to support patients and associates throughout the pandemic, gratitude for the ongoing heroism of Ascension associates and caregivers, Ascension’s work to distribute more than 1 million doses of the COVID-19 vaccines, and the importance of pursuing health equity and eliminating barriers to access to care.

Additionally, he describes the role of leaders in a crisis and highlights Ascension’s ABIDE framework and its call to Listen-Pray-Learn-Act to advance diversity, inclusion and justice.

Recent National News
Ascension’s Use of Digital Nudge Technology to Close Preventive Care Gaps Featured in NEJM Evidence
News Articles

Ascension’s Use of Digital Nudge Technology to Close Preventive Care Gaps Featured in NEJM Evidence

Ascension is featured in a recently published article in NEJM Evidence for innovative use of digital nudge technology to improve preventive care delivery in primary care settings.
Reducing preventable emergency department visits
News Articles

Reducing preventable emergency department visits

Ascension is on track to reduce avoidable emergency department visits by 5% across our care footprint.
Ascension Reports Strong Q3 FY25 Financial Performance, Strengthening Access to Care and Community Impact
News Releases

Ascension Reports Strong Q3 FY25 Financial Performance, Strengthening Access to Care and Community Impact

Ascension has released its third-quarter financial results for the nine months ended March 31, 2025 (Q3 FY25 YTD).